Suchergebnisse

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices. ; La loi de bioéthique a été révisée en 2021 pour tenir compte des avancées sociétales et médicales, notamment en matière d'aide médicale à la procréation (AMP). Un des objectifs était de limiter les recours à l'AMP qui se font en dehors du cadre légal et médical français. Comparativement à d'autres pays européens, la législation française reste néanmoins restrictive et ces recours pourraient perdurer. Pour mieux comprendre la situation et anticiper les évolutions, l'Ined lance l'enquête AMP-sans-frontières pour étudier la diversité des expériences et pratiques de l'aide à la procréation.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices. ; La loi de bioéthique a été révisée en 2021 pour tenir compte des avancées sociétales et médicales, notamment en matière d'aide médicale à la procréation (AMP). Un des objectifs était de limiter les recours à l'AMP qui se font en dehors du cadre légal et médical français. Comparativement à d'autres pays européens, la législation française reste néanmoins restrictive et ces recours pourraient perdurer. Pour mieux comprendre la situation et anticiper les évolutions, l'Ined lance l'enquête AMP-sans-frontières pour étudier la diversité des expériences et pratiques de l'aide à la procréation.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices. ; La loi de bioéthique a été révisée en 2021 pour tenir compte des avancées sociétales et médicales, notamment en matière d'aide médicale à la procréation (AMP). Un des objectifs était de limiter les recours à l'AMP qui se font en dehors du cadre légal et médical français. Comparativement à d'autres pays européens, la législation française reste néanmoins restrictive et ces recours pourraient perdurer. Pour mieux comprendre la situation et anticiper les évolutions, l'Ined lance l'enquête AMP-sans-frontières pour étudier la diversité des expériences et pratiques de l'aide à la procréation.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices. ; La loi de bioéthique a été révisée en 2021 pour tenir compte des avancées sociétales et médicales, notamment en matière d'aide médicale à la procréation (AMP). Un des objectifs était de limiter les recours à l'AMP qui se font en dehors du cadre légal et médical français. Comparativement à d'autres pays européens, la législation française reste néanmoins restrictive et ces recours pourraient perdurer. Pour mieux comprendre la situation et anticiper les évolutions, l'Ined lance l'enquête AMP-sans-frontières pour étudier la diversité des expériences et pratiques de l'aide à la procréation.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices. ; La loi de bioéthique a été révisée en 2021 pour tenir compte des avancées sociétales et médicales, notamment en matière d'aide médicale à la procréation (AMP). Un des objectifs était de limiter les recours à l'AMP qui se font en dehors du cadre légal et médical français. Comparativement à d'autres pays européens, la législation française reste néanmoins restrictive et ces recours pourraient perdurer. Pour mieux comprendre la situation et anticiper les évolutions, l'Ined lance l'enquête AMP-sans-frontières pour étudier la diversité des expériences et pratiques de l'aide à la procréation.

International audience ; The French bioethics law was amended in 2021 to take account of medical and societal advances, notably regarding medically assisted reproduction (MAR). One of its aims is to limit use of MAR outside the legal and medical framework. French legislation nonetheless remains restrictive compared with other European countries, so the practice is liable to continue. To shed light on the current situation and anticipate future developments, INED is launching the Outside-ART survey to study the diverse range of assisted reproductive experiences and practices.

International audience ; Use of new reproductive technology for surrogacy has raised controversies, especially when it involves parents and women from different origins and social classes. Before the political changes, it was the case of India which had become one of the leading international destinations for surrogacy. Little is known however about the representations and experiences of people involved, of surrogates particularly. Based on a 2-year field study and other empirical research work, the objective is here to analyze surrogates profiles, motivations, and experiences and to show that surrogacy in India is a very complex issue concerning gender. Development of surrogacy in India is partly due to its substantial reserve of "reproductive labor force." However, contrary to what is usually assumed, Indian surrogates are neither the least educated nor the poorest. Their motivation is nevertheless financial. Indian women enter in surrogacy process to fulfill their gender role as mother and spouse. Surrogacy may also be approached as a potential empowerment of women, who develop resistance and valorization strategies and take their family's destiny in hand. Long-term studies need however to be further developed to evaluate the real impact of this practice on their socio-economic and gender conditions.

International audience ; Study question: What are the characteristics, motivation and experience of French patients seeking cross-border reproductive care (CBRC)?Summary answer: French patients seeking CBRC are same-sex couples, single women who are not eligible for assisted reproduction technologies (ARTs) in France and heterosexual couples seeking oocyte donation due to extremely limited access to this technique in France, while their choice of Greece as a destination is influenced by financial issues.What is known already: CBRC is a new, increasing, complex and poorly understood phenomenon. A few studies have investigated UK, German or Italian CBRC patients, but none have specifically investigated French patients although France is one of the top four countries of origin of CBRC patients in Europe.Study design, size, duration: A cross-sectional study was carried out in 2010–2012 in three ART centres in Greece, Belgium and Spain in order to investigate French patients treated in these centres. Recruitment was prospective in Greece and Belgium and retrospective in Spain. The overall response rate was 68%, with 128 French patients participating.Participants/materials, setting, methods: French patients filled in a questionnaire. Information was collected on their socioeconomic characteristics and their search for ART treatment in France and in other countries.Main results and the role of chance: In the Belgian centre, 89% of French patients used sperm donation whereas oocyte donation was used by 100% of patients in the Greek centre and 74% of patients in the Spanish centre. The majority (94%) of French patients using sperm donation in Belgium were not legally eligible for access to ART in France as they were same-sex couples or single women, and the main criterion of choice of centre was its geographical proximity (71%). Most of the French patients using oocyte donation in Greece and Spain fulfilled criteria for fully reimbursed oocyte donation treatment in France as they were heterosexual couples (99%) with the woman aged ,43 years (65%). For these couples, CBRC was motivated by the extremely limited access to oocyte donation in France. Half of French CBRC patients using oocyte donation in Spain had a low/intermedi-ate occupational level (such as primary school teachers, nurses, administrative officers or sales agents, workers and employees) and this proportion was much higher in Greece (82%, P , 0.01).Limitations, reasons for caution: Larger and more wide-ranging studies are needed as this study included only 128 patients who may not be representative of all French CBRC patients, especially because the study was carried out only in three ART centres and these too may not be representative.Wider implications of the findings: CBRC among French patients had been thought to reflect mainly law evasion. This study showed that the reality is much more complex and that CBRC among French patients reflects both law evasion and limited access to oocyte donation in France. It also brings new insight into the characteristics of the patients by suggesting a certain degree of 'democratization' in access to such care. However, the choice of centre seemed related to socioeconomic characteristics, in that the Greek centre treated a less advantaged population than the Spanish centre.